Urteste S.A. (WSE: URT)

Poland flag Poland · Delayed Price · Currency is PLN
93.00
+2.00 (2.20%)
Sep 27, 2024, 4:32 PM CET
-12.26%
Market Cap 131.10M
Revenue (ttm) 1.01M
Net Income (ttm) -4.28M
Shares Out 1.41M
EPS (ttm) -3.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 58
Open 92.00
Previous Close 91.00
Day's Range 90.20 - 93.00
52-Week Range 79.80 - 112.50
Beta 0.22
Analysts n/a
Price Target n/a
Earnings Date Sep 17, 2024

About Urteste

Urteste S.A. engages in the research and development of diagnostic tests for cancers. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, stomach, lung, oesophagus, ovary, endometrium, blood, breast, and nervous system cancer. The company was incorporated in 2021 and is based in Gdansk, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2021
Employees 26
Stock Exchange Warsaw Stock Exchange
Ticker Symbol URT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.